Percutaneous coronary intervention or thrombolytics in ST-elevation infarction. What is the emperor really wearing?
Dellborg
M
M
Sahlgrenska University Hospital/Ostra, SE-416 85 Göteborg, Sweden. mikael.dellborg@hjl.gu.se
D000208:Acute Disease; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy / Q000009:adverse effects
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight